OPALEYE MANAGEMENT Overview

Opaleye Management Inc. is a hedge fund that manages 225.1 MM dollars in regulatory AUM and has 3 employees, of which 3 perform investment advisory functions.

The manager's has disclosed holdings from 12/31/13 to 09/30/16. The fund's latest filing disclosed 183MM in positions, representing 81% of the manager's regulatory AUM.

OPALEYE MANAGEMENT StockAlpha

+5.2%
Top 25%
3yr StockAlpha Register for more...

Fundamental & Technical Factor Exposure

Market Cap Beta Volatility
Momentum (12M) Momentum (6M) Momentum (3M)
Price/Book Price/Earnings Price/Cash Flow
Dividend Yield Sales Growth Earnings Growth
ROE ROA ROC
EBIDTA Margin Debt/Assets Hedge Fund Crowding

OPALEYE MANAGEMENT Since Last Filing Return Details

Ticker Size Sector Stock Move StockAlpha Attribution Days to Liquidate Trade Crowdedness
BPMC 12.76% Health -11.78% -0.73% 4 1%
AXGN 9.89% Health -7.53% -0.36% 5 2%
Unlock Positions and Returns Details
FEATURED IN
Logo of CNBC
Wall Street Journal Logo
Pensions & Investments logo
BloomBerg Logo

OPALEYE MANAGEMENT Founders and Key Employees

Name Title In Position Since
James A. Silverman President/Chief Compliance Officer February-1996

OPALEYE MANAGEMENT Brokers, Custodians, Auditors and Administrators

Type Company
Administrator Pro
Auditor Pro
Custodian Pro
Custodian Pro
Prime Broker Pro

OPALEYE MANAGEMENT Investment Strategy

Methods of Analysis, Investment Strategies and Risk of Loss



We employ a research process that involves analyzing company fundamentals. Such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition.

Opaleye's strategy for managing the Fund is to actively invest, both long and short, in equity securities of biotechnology, specialty pharmaceutical and med-device companies. In pursuing this strategy, the Fund will focus its long investments in equity securities of companies that may not be profitable yet but whose share price may grow significantly in the near term or over a 1-2 year or longer period based on their therapeutic development and financial objectives. The Fund will also seek to actively invest in stock and derivative transactions to profit from “binary” events, such as clinical data milestones or a U.S. Food and Drug Administration (“FDA...
Unlock Full Investment Process Description

OPALEYE MANAGEMENT Portfolio Concentration

OPALEYE MANAGEMENT Location


OPALEYE MANAGEMENT Contact Information

Phone Number: 617-229-5085
Fax Number: 617-812-0515
Website:

READ RECENT SYMMETRIC REPORTS

Disclaimer

The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here
Path A